• Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
  (Atkinson RD, et.al. Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E284-90. Epub 2007 Nov 20.)
  View Abstract

• Normal value of carotid intima-media thickness--a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound.
  (Lim TK, et.al. J Am Soc Echocardiogr. 2008 Feb;21(2):112-6. Epub 2007 Aug 30.)
  View Abstract
• Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine.
  (Liu C, et.al. J Nutr. 2008 Feb;138(2):311-5.)
  View Abstract

• Influence of the duration of Type 2 diabetes on early functional and morphological markers of atherosclerosis compared to the impact of coexisting classic cardiovascular risk factors.
  (Meyer MF, et.al. Exp Clin Endocrinol Diabetes. 2008 Feb 14; [Epub ahead of print])
  View Abstract

top

Drug Therapy

• Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
  (Lorenz MW, et.al. Atherosclerosis. 2008 Feb;196(2):720-6. Epub 2007 Feb 1.)
  View Abstract
• Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
  (Glintborg D, et.al. Diabetes Care. 2008 Feb;31(2):328-34. Epub 2007 Nov 13.)
  View Abstract
• Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
  (Black HR, et.al. Diabetes Care. 2008 Feb;31(2):353-60. Epub 2007 Nov 13.)
  View Abstract
• New approaches to the concept of primary prevention of atherosclerosis.
  (Ford MA, et.al. Curr Treat Options Cardiovasc Med. 2008 Feb;10(1):73-82.)
  View Abstract
• Direct effect of statins on homocysteine-induced endothelial adhesiveness: potential impact to human atherosclerosis.
  (Lin CP, et.al. Eur J Clin Invest. 2008 Feb;38(2):106-16.)
  View Abstract
• Translating molecular discoveries into new therapies for atherosclerosis.
  (Rader DJ, et.al. Nature. 2008 Feb 21;451(7181):904-13.)
  View Abstract
• Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model.
  (Hernandez-Trujillo Y, et.al. Cardiovasc Diabetol. 2008 Feb 26;7:3.)
  View Abstract
• Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein e-knockout mice.
  (Yao R, et.al. J Cardiovasc Pharmacol. 2008 Feb;51(2):188-95.)
  View Abstract
• Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit.
  (Maranhão RC, et.al. Atherosclerosis. 2008 Feb 18; [Epub ahead of print])
  View Abstract

top

Epidemiology

• Prevalence of and risk factors for subclinical cardiovascular disease in selected US hispanic ethnic groups: The multi-ethnic study of atherosclerosis.
  (Allison MA, et.al. Am J Epidemiol. 2008 Feb 17; [Epub ahead of print])
  View Abstract
• Primary hypercholesterolemia, carotid atherosclerosis and insulin resistance among chinese.
  (Chien KL, et.al. Lipids. 2008 Feb;43(2):117-24. Epub 2007 Dec 15.)
  View Abstract

• Factors contributing to the risk of cardiovascular disease reflected by plasma adiponectin Data from the coronary risk factors for atherosclerosis in women (CORA) study.
  (Zyriax BC, et.al. Atherosclerosis. 2008 Feb 7; [Epub ahead of print])
  View Abstract

top

Genetics of Cardiovascular Disease

• Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
  (Hu Q, et.al. Hum Gene Ther. 2008 Feb 26; [Epub ahead of print])
  View Abstract
• Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.
  (Martinelli N, et.al. PLoS ONE. 2008 Feb 6;3(2):e1523.)
  View Abstract
• The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis.
  (Niemiec P, et.al. Clin Chem Lab Med. 2008 Feb 26; [Epub ahead of print])
  View Abstract
• The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
  (Mäkelä R, et.al. Clin Biochem. 2008 Feb 6; [Epub ahead of print])
  View Abstract
• Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan.
  (Hsieh YC, et.al. Toxicol Appl Pharmacol. 2008 Feb 15;227(1):1-7. Epub 2007 Oct 22.)
  View Abstract
• Association analysis of allelic variants of USF1 in coronary atherosclerosis.
  (Kristiansson K, et.al. Arterioscler Thromb Vasc Biol. 2008 Feb 14; [Epub ahead of print])
  View Abstract
• Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels.
  (Out R, et.al. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):258-64. Epub 2007 Nov 15.)
  View Abstract
• Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
  (Tsai MY, et.al. Atherosclerosis. 2008 Feb 1; [Epub ahead of print])
  View Abstract
• A pleiotropic QTL on 2p influences serum Lp-PLA2 activity and LDL cholesterol concentration in a baboon model for the genetics of atherosclerosis risk factors.
  (Vinson A, et.al. Atherosclerosis. 2008 Feb;196(2):667-73. Epub 2007 Sep 4.)
  View Abstract

• Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
  (Lancelot E, et.al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):425-32. Epub 2008 Feb 7.)
  View Abstract
• Angiography underestimates peripheral atherosclerosis: lumenography revisited.
  (Kashyap VS, et.al. J Endovasc Ther. 2008 Feb;15(1):117-25.)
  View Abstract
• Carotid intima-media thickness testing by non-sonographer clinicians: the office practice assessment of carotid atherosclerosis study.
  (Korcarz CE, et.al. J Am Soc Echocardiogr. 2008 Feb;21(2):117-22. Epub 2007 Sep 29.)
  View Abstract
• Medical diagnosis of atherosclerosis from Carotid Artery Doppler Signals using principal component analysis (PCA), k-NN based weighting pre-processing and Artificial Immune Recognition System (AIRS).
  (Latifog(lu F, et.al. J Biomed Inform. 2008 Feb;41(1):15-23. Epub 2007 Apr 11.)
  View Abstract
• p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
  (Morris JB, et.al. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):265-71. Epub 2007 Dec 27.)
  View Abstract
• No correlation and low agreement of imaging and inflammatory atherosclerosis' markers in familial hypercholesterolemia.
  (Martinez LR, et.al. Atherosclerosis. 2008 Feb 4; [Epub ahead of print])
  View Abstract
• Repeatability limits for measurement of coronary artery calcified plaque with cardiac CT in the Multi-Ethnic Study of Atherosclerosis.
  (Chung H, et.al. AJR Am J Roentgenol. 2008 Feb;190(2):W87-92.)
  View Abstract
• Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA).
  (Wasserman BA, et.al. Stroke. 2008 Feb;39(2):329-35. Epub 2008 Jan 3.)
  View Abstract
• Characterization of Carotid Atherosclerosis and Detection of Soft Plaque With Use of Black-Blood MR Imaging.
  (Yoshida K, et.al. AJNR Am J Neuroradiol. 2008 Feb 22; [Epub ahead of print])
  View Abstract
• Association of intracellular pro- and anti-inflammatory cytokines in peripheral blood with the clinical or ultrasound indications for carotid endarterectomy in patients with carotid atherosclerosis.
  (Profumo E, et.al. Clin Exp Immunol. 2008 Apr;152(1):120-6. Epub 2008 Feb 25.)
  View Abstract

top

• Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.
  (Waldman WJ, et.al. Brain Behav Immun. 2008 Feb;22(2):215-23. Epub 2007 Sep 12.)
  View Abstract
• The roles of pathogen-associated molecular patterns in atherosclerosis.
  (Erridge C.Trends Cardiovasc Med. 2008 Feb;18(2):52-6.)
  View Abstract

top

Inflammation

• Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.
  (Ohman MK, et.al. Circulation. 2008 Feb 12;117(6):798-805. Epub 2008 Jan 22.)
  View Abstract
• CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
  (Olofsson PS, et.al. Circulation. 2008 Mar 11;117(10):1292-301. Epub 2008 Feb 19.)
  View Abstract
• Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.
  (Szeto CC, et.al. Clin J Am Soc Nephrol. 2008 Mar;3(2):431-6. Epub 2008 Feb 6.)
  View Abstract
• Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE-/- mice.
  (Mishima T, et.al. Int J Mol Med. 2008 Feb;21(2):181-7.)
  View Abstract
• Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity.
  (Alizadeh Dehnavi R, et.al. Atherosclerosis. 2008 Feb 18; [Epub ahead of print])
  View Abstract
• High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
  (Duygu H, et.al. Int J Cardiol. 2008 Feb 29;124(2):267-70. Epub 2007 Mar 28.)
  View Abstract

top

Innovative Techniques and Modeling

• Duplex ultrasound of the superficial femoral artery is a better screening tool than ankle-brachial index to identify at risk patients with lower extremity atherosclerosis.
  (Flanigan DP, et.al. J Vasc Surg. 2008 Feb 13; [Epub ahead of print])
  View Abstract
• Availability of Cardio-Ankle Vascular Index (CAVI) as a Screening Tool for Atherosclerosis.
  (Kadota K, et.al. Circ J. 2008 Feb;72(2):304-8.)
  View Abstract
• Microarray gene profiling of laser-captured cells: A new tool to study atherosclerosis in mice.
  (Paul A, et.al. Atherosclerosis. 2008 Feb 18; [Epub ahead of print])
  View Abstract

top

Lipid & Lipoprotein Metabolism

• Conjugated linoleic acid isomers have no effect on atherosclerosis and adverse effects on lipoprotein and liver lipid metabolism in apoE(-/-) mice fed a high-cholesterol diet.
  (Cooper MH, et.al. Atherosclerosis. 2008 Feb 14; [Epub ahead of print])
  View Abstract

top

Liver Disease

• Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.
  (Biddinger SB, et.al. Cell Metab. 2008 Feb;7(2):125-34.)
  View Abstract

top

Menopause

• Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease.
  (Gatto NM, et.al. Atherosclerosis. 2008 Feb;196(2):674-81. Epub 2007 Sep 4.)
  View Abstract
• Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: The Atherosclerosis Risk in Communities (ARIC) Study.
  (Chamberlain AM, et.al. Atherosclerosis. 2008 Feb 12; [Epub ahead of print])
  View Abstract

top

Metabolic Syndrome

• Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.
  (Chung CP, et.al. Atherosclerosis. 2008 Feb;196(2):756-63. Epub 2007 Jan 30.)
  View Abstract
• Metabolic syndrome: A major risk factor for atherosclerosis in HIV-infected patients (SHIVA study).
  (Martin LD, et.al. Presse Med. 2008 Feb 28; [Epub ahead of print])
  View Abstract

top

Nutrition / Diet / Metabolism

• Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study.
  (Lutsey PL, et.al. Circulation. 2008 Feb 12;117(6):754-61. Epub 2008 Jan 22.)
  View Abstract
• Associations of the Local Food Environment with Diet Quality--A Comparison of Assessments based on Surveys and Geographic Information Systems: The Multi-Ethnic Study of Atherosclerosis.
  (Moore LV, et.al. Am J Epidemiol. 2008 Feb 27; [Epub ahead of print])
  View Abstract
• Vitamin K intake and atherosclerosis.
  (Erkkilä AT, et.al. Curr Opin Lipidol. 2008 Feb;19(1):39-42.)
  View Abstract

top

Obesity

• Correlations of visceral fat accumulation and atherosclerosis in Japanese patients with type 2 diabetes mellitus.
  (Anan F, et.al. Metabolism. 2008 Feb;57(2):280-4.)
  View Abstract
• Birth weight is not related to risk of diabetic retinopathy in type 2 diabetes: The atherosclerosis risk in communities study.
  (Liew G, et.al. Curr Eye Res. 2008 Feb;33(2):193-8.)
  View Abstract

top

Oxidative Stress

• Are uremia, diabetes, and atherosclerosis linked with impaired antioxidant mechanisms?
  (Dursun B, et.al. J Investig Med. 2008 Feb;56(2):545-52.)
  View Abstract
• Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis.
  (Guns PJ, et.al. Br J Pharmacol. 2008 Feb;153(3):508-16. Epub 2007 Dec 3.)
  View Abstract

top

Peripheral Disease

• Albuminuria and peripheral arterial disease: Results from the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Wattanakit K, et.al. Atherosclerosis. 2008 Feb 15; [Epub ahead of print])
  View Abstract

top

Plaque Biology

• A potential role of the CXC chemokine GRO{alpha} in atherosclerosis and plaque destabilization. Downregulatory effects of statins.
  (Breland UM, et.al. Arterioscler Thromb Vasc Biol. 2008 Feb 14; [Epub ahead of print])
  View Abstract
• Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: an autopsy study.
  (Dalager S, et.al. J Vasc Surg. 2008 Feb;47(2):296-302.)
  View Abstract
• Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes.
  (Fougerat A, et.al. Circulation. 2008 Mar 11;117(10):1310-7. Epub 2008 Feb 11.)
  View Abstract

top

Risk Factors

• Insulin resistance as a risk factor for carotid atherosclerosis. A comparison of the homeostasis model assessment and the short insulin tolerance test.
  (Sourij H, et.al. Stroke. 2008 Feb 28; [Epub ahead of print])
  View Abstract
• Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
  (Ayoub S, et.al. Nat Clin Pract Rheumatol. 2008 Feb;4(2):98-105. Review.)
  View Abstract
• Xanthelasma is not associated with increased risk of carotid atherosclerosis in normolipidaemia.
  (Chan CC, et.al. Int J Clin Pract. 2008 Feb;62(2):221-7. Epub 2007 Nov 23.)
  View Abstract
• Atherosclerosis and osteoporosis.
  (Pérez Castrillón JL, et.al. Minerva Med. 2008 Feb;99(1):45-54.)
  View Abstract
• Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea?
  (Saletu M, et.al. Atherosclerosis. 2008 Feb;196(2):810-6. Epub 2007 Mar 13.)
  View Abstract

top

Stroke

• Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis.
  (Abboud S, et.al. Eur J Hum Genet. 2008 Feb 27; [Epub ahead of print])
  View Abstract
• Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study.
  (Kohsaka S, et.al. Atherosclerosis. 2008 Feb;196(2):926-30. Epub 2007 Mar 9.)
  View Abstract
• Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke.
  (Mazighi M, et.al. Stroke. 2008 Feb 28; [Epub ahead of print])
  View Abstract
• Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case control study.
  (Alamowitch S, et.al. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):147-51. Epub 2007 Oct 2.) View Abstract
• High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review.
  (Amarenco P, et.al. Atherosclerosis. 2008 Feb;196(2):489-96. Epub 2007 Oct 17.)
  View Abstract

top

Vascular Biology

• The effect of large unilamellar vesicles on vascular function in patients with coronary atherosclerosis.
  (Anderson T, et.al. Atherosclerosis. 2008 Feb 7; [Epub ahead of print])
  View Abstract
• Region-specific patterns of vascular remodelling occur early in atherosclerosis and without loss of smooth muscle cell markers.
  (Handa S, et.al. Atherosclerosis. 2008 Feb;196(2):617-23. Epub 2007 Aug 9.)
  View Abstract
• Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score.
  (Junyent M, et.al. Atherosclerosis. 2008 Feb;196(2):803-9. Epub 2007 Feb 21.)
  View Abstract
• Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
  (Kanse SM, et.al. Thromb Haemost. 2008 Feb;99(2):286-9.)
  View Abstract
• Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients.
  (Marfella R, et.al. J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):200-3.)
  View Abstract
• Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol.
  (Rizzo M, et.al. Atherosclerosis. 2008 Feb 5; [Epub ahead of print])
  View Abstract
• Ceramide: a common pathway for atherosclerosis?
  (Bismuth J, et.al. Atherosclerosis. 2008 Feb;196(2):497-504. Epub 2007 Oct 25.)
  View Abstract
• Role of smooth muscle cells in the initiation and early progression of atherosclerosis.
  (Doran AC, et.al. Arterioscler Thromb Vasc Biol. 2008 Feb 14; [Epub ahead of print])
  View Abstract
• Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis.
  (Fortunato G, et.al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):594-600. Epub 2008 Feb 7.)
  View Abstract
• Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
  (Siegel-Axel D, et.al. Cardiovasc Res. 2008 Feb 20; [Epub ahead of print])
  View Abstract
• Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.
  (Zernecke A, et.al. Circ Res. 2008 Feb 1;102(2):209-17. Epub 2007 Nov 8.)
  View Abstract
• Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
  (Watanabe T, et.al. Circulation. 2008 Feb 5;117(5):638-48. Epub 2008 Jan 22.)
  View Abstract
• Subclinical coronary atherosclerosis and resting ECG abnormalities in an unselected general population.
  (Möhlenkamp S, et.al. Atherosclerosis. 2008 Feb;196(2):786-94. Epub 2007 Mar 13.)
  View Abstract
• Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine.
  (O'Kane PD, et.al. Atherosclerosis. 2008 Feb;196(2):574-9. Epub 2007 Jul 26.)
  View Abstract
• Associations of psychosocial factors with heart rate and its short-term variability: multi-ethnic study of atherosclerosis.
  (Ohira T, et.al. Psychosom Med. 2008 Feb;70(2):141-6. Epub 2008 Feb 6.)
  View Abstract
• Deficiency of invariant V{alpha}14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
  (Rogers L, et.al. Cardiovasc Res. 2008 Feb 12; [Epub ahead of print])
  View Abstract
• Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice.
  (Samokhin AO, et.al. Atherosclerosis. 2008 Feb 19; [Epub ahead of print])
  View Abstract
• Screening for thoracoabdominal aortic aneurysms in patients with aortoiliac atherosclerosis: a preliminary study.
  (Shakeri AB, et.al. Folia Morphol (Warsz). 2008 Feb;67(1):78-83.)
  View Abstract
• TLR2 in murine atherosclerosis.
  (Tobias PS, et.al. Semin Immunopathol. 2008 Feb;30(1):23-7. Epub 2007 Dec 6.)
  View Abstract
• Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis.
  (Van der Heiden K, et.al. Atherosclerosis. 2008 Feb;196(2):542-50. Epub 2007 Jul 13.)
  View Abstract
• Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II.
  (Weiss D, et.al. Hypertension. 2008 Feb;51(2):218-24. Epub 2007 Dec 24.)
  View Abstract
• Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus.
  (Fukui M, et.al. Metabolism. 2008 Feb;57(2):285-9.)
  View Abstract
• Endothelial Arginase II. A novel target for the treatment of atherosclerosis.
  (Ryoo S, et.al. Circ Res. 2008 Feb 28; [Epub ahead of print])
  View Abstract
• IL-33 reduces the development of atherosclerosis.
  (Miller AM, et.al. J Exp Med. 2008 Feb 18;205(2):339-46. Epub 2008 Feb 11.)
  View Abstract
• Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.
  (Zhang X, et.al. Circ Res. 2008 Feb 1;102(2):250-6. Epub 2007 Nov 21.)
  View Abstract

top

Vascular Calcification

• Sex hormones, sex hormone binding globulin, and abdominal aortic calcification in women and men in the multi-ethnic study of atherosclerosis (MESA).
  (Michos ED, et.al. Atherosclerosis. 2008 Feb 7; [Epub ahead of print])
  View Abstract

top

Recommended Reading

The following articles were recommended by Dr. Eder Quintão.

• Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice.
  (Tang W, et al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):448-54. Epub 2008 Jan 10.)
  View Abstract
• C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells.
  (Wang X, et al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):519-26. Epub 2007 Dec 20.)
  View Abstract
• Synthesis and absorption of cholesterol in Finnish boys by serum non-cholesterol sterols The cardiovascular risk in young Finns study.
  (Miettinen TA, et al. Atherosclerosis. 2008 Jan 4; [Epub ahead of print])
  View Abstract
• Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population.
  (Polisecki E, et. al. Atherosclerosis. 2008 Feb 7; [Epub ahead of print])
  View Abstract
• Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.
  (Ooi EM, et al. J Clin Endocrinol Metab. 2008 Feb;93(2):430-7. Epub 2007 Nov 20.)
  View Abstract
• Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.
  (Lu H, et al. J Clin Invest. 2008 Mar 3;118(3):984-993.)
  View Abstract
• Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
  (Millar JS, et al. J Lipid Res. 2008 Mar;49(3):543-9. Epub 2007 Nov 21.)
  View Abstract
• Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
  (Nelbach L, et al. J Lipid Res. 2008 Mar;49(3):572-80. Epub 2007 Dec 3.)
  View Abstract
• Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects.
  (Catalano G, et al. J Lipid Res. 2008 Mar;49(3):635-43. Epub 2007 Dec 5.)
  View Abstract
• Relation of cholesterol metabolism and non-cholesterol sterols to insulin resistance.
  (Smahelová A, et al. Physiol Res. 2007;56(6):749-55. Epub 2006 Nov 6.)
  View Abstract
• SREBPs: the crossroads of physiological and pathological lipid homeostasis.
  (Raghow R, et al. Trends Endocrinol Metab. 2008 Mar;19(2):65-73.)
  View Abstract

top